[Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
D000017:ABO Blood-Group System; D000917:Antibody Formation; D000918:Antibody Specificity; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007106:Immune Sera; D007072:Immunoglobulin D; D007074:Immunoglobulin G / Q000627:therapeutic use; D007136:Immunoglobulins / Q000627:therapeutic use*; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D007106:Immune Sera; D007072:Immunoglobulin D; D007074:Immunoglobulin G; D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System
Prophylaxe der Rhesus-Sensibilisierung durch intravenöse Gabe von Immunglobulin G Anti-D. II. Generelle Prophylaxe mit niedrigen, dem Ausmass der fetomaternalen Transfusion angepassten Dosen von IgG Anti-.